Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS.W


Primary Symbol: T.SZLS Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > New Press Release - StageZero Life Sciences, Ltd. Special and Annual General Meeting Conference Call
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(260)
•••
Comment by Nailbiter2on Jun 06, 2023 7:24pm
93 Views
Post# 35483431

RE:RE:RE:RE:New Press Release - StageZero Life Sciences, Ltd. Special and Annual General Meeting Conference Call

RE:RE:RE:RE:New Press Release - StageZero Life Sciences, Ltd. Special and Annual General Meeting Conference Call
telman wrote: Um I'm the guy that asked him about the $4M on the last conference call that led to him letting the cat out of the bag that they had lied to investors when they released the NR about $4M a year by CARE.

Im also the person that emailed them asking about warrants and was told that they are thinking about it that I shared with the board.

I forget though what have you shared with the board other than these pointless memes or gifs?

Sorry for asking a board that is apparently interested in the company (since they own shares) to try to get answers or pressure this management into to either doing something or making themselves look bad enough that we could actually get someone good in there.  It was stupid of me to ask and foolish to think any investor would care about warrants or being lied to.

Instead you can continue with your meme's and talk so that Tripp will be continued to do what he has been doing for the past how many years now?


If that was you on the last call, then good on ya for bringing that up to Tripp.
Didn't realize.
Too many spineless criers here not willing to confront.

Apologies to you.
I'm sure that you or somebody other than yourself will put a hot iron at James' feet.
As far as the warrants, I'm sure they will be pushed into some ray of sunshine in the future.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities